Everything You Should Know About Ozempic
April 6, 2021
Semaglutide (Ozempic) is a glucagon-like peptide-1 (GLP-1) receptor agonist that has been approved for the treatment of type 2 diabetes. In a recent study, researchers investigated the efficacy and safety of once-weekly semaglutide in adults with overweight or obesity.